Information:
Fel:
ID
21447
Beskrivning
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193453
Länk
https://clinicaltrials.gov/show/NCT00193453
Nyckelord
Versioner (1)
- 2017-04-21 2017-04-21 -
Uppladdad den
21 april 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Lung Cancer NCT00193453
Eligibility Lung Cancer NCT00193453
- StudyEvent: Eligibility
Similar models
Eligibility Lung Cancer NCT00193453
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Criteria Fulfill
Item
to be included in the study, you must meet the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Biopsy
Item
non-small cell lung cancer confirmed by biopsy
boolean
C0007131 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
Disease unresectable TNM clinical staging
Item
unresectable stage iii or iv disease
boolean
C0012634 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Carcinoma of lung Chemotherapy Absent
Item
must not have received any prior chemotherapy for lung cancer
boolean
C0684249 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Activities of Daily Living Perform Able
Item
able to perform activities of daily living without considerable assistance
boolean
C0001288 (UMLS CUI [1,1])
C0884358 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0884358 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Bone Marrow function | Renal function | Liver function
Item
adequate bone marrow, kidney, and liver function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status
Item
you cannot participate in the study if any of the following apply to you:
boolean
C2348568 (UMLS CUI [1])
Heart Disease Serious
Item
history of serious heart disease within six months prior to study entry
boolean
C0018799 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Pharmaceutical Preparations Targeting EGFR pathway
Item
prior treatment with agents that target the egfr pathway
boolean
C0013227 (UMLS CUI [1,1])
C1521840 (UMLS CUI [1,2])
C1155379 (UMLS CUI [1,3])
C1521840 (UMLS CUI [1,2])
C1155379 (UMLS CUI [1,3])
Disease Uncontrolled | Disease Significant
Item
history of any other uncontrolled or significant disease
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
Clinical Trial Eligibility Criteria Additional
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have. you can then decide if you wish to participate.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])